4-Ethoxy-2-methylpyrimidine

Catalog No.: 
ACKJZN712
CAS No.: 
24903-66-0
Molecular Formula: 
C7H10N2O
Molecular Weight: 
138.17
4-Ethoxy-2-methylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$96.00In stockInquiry
25g95%$475.00InquiryInquiry
100g95%$1862.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Ethoxy-2-methylpyrimidine
IUPAC Name4-ethoxy-2-methylpyrimidine
Molecular FormulaC7H10N2O
Molecular Weight138.17
SMILESCCOC1=CC=NC(C)=N1
InChI KeyRXMPKZPQPXECBZ-UHFFFAOYSA-N
SynonymPyrimidine, 4-ethoxy-2-methyl- (8CI);Pyrimidine, 4-ethoxy-2-methyl-
CAS No.24903-66-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACKJZN712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACNXKW968 route compound structure diagram
    ACNXKW9684994-86-9In Stock
  4. Then
  5. ACKJZN712 route product structure diagram
    ACKJZN71224903-66-0In Stock
Inquiry

2. ACKJZN712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACNXKW968 route compound structure diagram
    ACNXKW9684994-86-9In Stock
  4. Then
  5. ACKJZN712 route product structure diagram
    ACKJZN71224903-66-0In Stock
Inquiry

3. ACKJZN712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACLDJU592 route compound structure diagram
    ACLDJU5921114560-76-7In Stock
  4. Then
  5. ACKJZN712 route product structure diagram
    ACKJZN71224903-66-0In Stock
Inquiry

Comments (0)